We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Liquid Biopsy Test Identifies Over 1,000 Pathogens from Single Blood Draw within 24 Hours

By LabMedica International staff writers
Posted on 11 Oct 2023

Pneumonia poses a serious health risk, especially for those currently being treated for blood cancer, who are generally more susceptible to infections. More...

Identifying the exact cause of pneumonia in such patients is both challenging and vital for effective treatment. Now, a blood test based on metagenomics next-generation sequencing (NGS) of microbial cell-free DNA has been shown to increase the identification of pathogens causing pneumonia in immunocompromised patients when combined with routine care diagnostic testing.

The Karius Test from Karius Inc. (Redwood City, CA, USA) is a liquid biopsy that can rapidly and non-invasively identify over 1,000 types of pathogens from just one blood sample. Its primary function is to assist doctors in diagnosing infections in immunocompromised patients. The test can identify a range of conditions, including pneumonia, invasive fungal infections, and others that could lead to fever in neutropenic patients. This innovative test could eliminate the need for multiple, invasive, and often inefficient diagnostic procedures, speeding up treatment for those who are critically ill. Results from the Karius Test are usually available the day after the sample is received, which is much faster than standard testing procedures that can take several days or even weeks.

The PICKUP Study, a pioneering collaborative research effort by ten top medical institutions, explored the additional diagnostic value that the Karius Test could provide in treating pneumonia in blood cancer patients. This study specifically looked at the percentage of patients for whom the Karius Test could identify the pneumonia-causing pathogen when standard diagnostic tests had failed to do so within seven days of admission. The study found that the test accurately identified the likely cause of pneumonia in 12% (21 out of 173) of patients when all other tests, including bronchoscopy, had failed. The research also highlighted that for 81% (17 out of 21) of these patients, the treatment could have been more effectively tailored if the Karius Test had been used. Moreover, the test was successful in detecting hard-to-identify pathogens such as Rhizomucor pusillus, Nocardia cyriacigeorgica, Legionella species, and Aspergillus fumigatus, among others, where traditional tests had come up short.

“These patients have much to gain through an improved etiologic diagnosis, and the better and more directed treatment of these infections that make this possible,” said Brad Perkins, Chief Medical Officer at Karius. “This is not only beneficial in the avoidance of the direct morbidity and mortality associated with these infections (26.6% of our enrolled patients died during this study) but in also gaining earlier and uninterrupted access to in-many-cases increasingly life-saving treatments for their underlying disease, in this case hematologic malignancies.”

Related Links:
Karius Inc. 


New
Gold Member
Latex Test
SLE-Latex Test
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
New
Vasculitis Diagnostic Test
AESKULISA Vasculitis-Screen
New
Hemoglobin Stool Test
CerTest FOB 50 + 200 One Step Combo Card Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: New biomarkers could someday make it easy to spot Parkinson’s disease in a patient’s blood sample (Photo courtesy of Shutterstock)

Unique Blood-Based Genetic Signature Can Diagnose Parkinson’s Disease

Parkinson's disease is primarily recognized for its impact on the central nervous system. Recent scientific progress has shifted focus to understanding the involvement of the immune system in the onset... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: Custom hardware and software for the real-time detection of immune cell biophysical signatures in NICU (Photo courtesy of Pediatric Research, DOI:10.1038/s41390-025-03952-y)

First-Of-Its-Kind Device Profiles Newborns' Immune Function Using Single Blood Drop

Premature infants are highly susceptible to severe and life-threatening conditions, such as sepsis and necrotizing enterocolitis (NEC). Newborn sepsis, which is a bloodstream infection occurring in the... Read more

Pathology

view channel
Image: The innovative doublet configuration and annular illumination overcome traditional metalens limitations (Photo courtesy of Tao Li and Jiacheng Sun/Nanjing University)

High-Resolution Metalens Doublet Microscope to Enhance Diagnostic Capabilities

Metalenses mark a groundbreaking leap in optical technology. Unlike traditional microscope objectives that rely on curved glass surfaces, metalenses utilize nanoscale structures to manipulate light at... Read more

Technology

view channel
Image: Concept of biosensor integrated into hygiene pads enabling direct semi-quantitative analysis of biomarkers in unprocessed menstruation blood (Photo courtesy of Dosnon, L et al. DOI: 10.1002/advs.202505170)

First Ever Technology Recognizes Disease Biomarkers Directly in Menstrual Blood in Sanitary Towels

Over 1.8 billion people menstruate worldwide, yet menstrual blood has been largely overlooked in medical practice. This blood contains hundreds of proteins, many of which correlate with their concentration... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.